Rhoen Klinikum AG (RHK) Receives Average Rating of “Hold” from Analysts

Share on StockTwits

Shares of Rhoen Klinikum AG (ETR:RHK) have been given an average rating of “Hold” by the eleven analysts that are currently covering the firm, MarketBeat reports. Five analysts have rated the stock with a sell rating and six have issued a hold rating on the company. The average 12-month target price among brokerages that have issued a report on the stock in the last year is €24.10 ($28.02).

A number of research analysts have recently weighed in on the company. Berenberg Bank set a €29.15 ($33.90) price target on Rhoen Klinikum and gave the company a “neutral” rating in a research note on Monday, May 14th. Cfra set a €25.00 ($29.07) price target on Rhoen Klinikum and gave the company a “sell” rating in a research note on Friday, August 3rd. Kepler Capital Markets set a €22.00 ($25.58) price target on Rhoen Klinikum and gave the company a “sell” rating in a research note on Thursday, August 2nd. Warburg Research set a €25.20 ($29.30) price target on Rhoen Klinikum and gave the company a “neutral” rating in a research note on Thursday, August 2nd. Finally, Commerzbank set a €25.00 ($29.07) price objective on Rhoen Klinikum and gave the stock a “neutral” rating in a research note on Thursday, August 2nd.

RHK stock opened at €21.50 ($25.00) on Friday. Rhoen Klinikum has a twelve month low of €25.08 ($29.16) and a twelve month high of €32.12 ($37.35).

Rhoen Klinikum Company Profile

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, builds, acquires, and operates primarily acute-care hospitals in Germany. Its hospitals offer treatment services primarily in the areas of cardiovascular, neurological disorders, oncology, pneumology, orthopedic, accident, and surgeries; rehabilitation and nursing services to the elderly; and thoracic, tumors, and psychosomatic, as well as spinal, column, and joints diseases.

See Also: What are the Benefits of Index Funds?

Analyst Recommendations for Rhoen Klinikum (ETR:RHK)

Receive News & Ratings for Rhoen Klinikum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rhoen Klinikum and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply